AbbVie
ABBV
#30
Rank
HK$2.319 T
Marketcap
HK$1,313
Share price
0.55%
Change (1 day)
21.81%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): HK$28.81

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.65. In 2022 the company made an earnings per share (EPS) of HK$51.82 an increase over its 2021 EPS that were of HK$50.49.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$28.81-44.4%
2022HK$51.822.63%
2021HK$50.49125.21%
2020HK$22.42-45.69%
2019HK$41.2848.35%
2018HK$27.827.6%
2017HK$25.86-9.3%
2016HK$28.5115.48%
2015HK$24.69185.53%
2014HK$8.65-57.11%
2013HK$20.16-21.69%
2012HK$25.7555.73%
2011HK$16.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.48-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.90 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.25 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.12 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$34.17 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.67 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.24-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.45-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.25-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA